Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 9 of 9 for “"IVT mRNA"”.
-
Ανάπτυξη mRNA μορίων στη θεραπευτική προσέγγιση μεταβολικών/μονογονιδιακών νοσημάτων με την αξιοποίηση της τεχνολογίας των πεπτιδίων μεταγωγτής (PTDs/CPPs)
The in vitro transcribed (IVT)-mRNA resembles the natural mRNA and its successful intracellular delivery allows the transient expression of the corresponding exogenous protein by the cells' own translational machinery. The strongest advantage of IVT-mRNA technology is that mRNA molecules do not …
-
Strategies for controlling the innate immune responses to in vitro transcribed messenger RNAs
Synthetic messenger RNA (mRNA) produced via in vitro transcription (IVT mRNA) has emerged as an appealing tool for the transient introduction of genes, particularly for vaccination applications. The interaction that IVT mRNA has with the innate immune system is centrally important to its …
-
mRNA-Encoded Anti-VapA Monoclonal IgG1 for Passive Immunization of Foals Against Rhodococcus equi
… limit feasibility. In vitro transcribed (IVT) mRNA encoding mAbs (mRNA-mAbs) enables safe, ondemand mAb production within the patient, including in the lungs following nebulized delivery of mRNA-mAbs. Thus, our objective was to generate IVT mRNA encoding an equine mAb of the IgG1 …
-
mRNA-Encoded Anti-VapA Monoclonal IgG1 for Passive Immunization of Foals Against Rhodococcus equi
… limit feasibility. In vitro transcribed (IVT) mRNA encoding mAbs (mRNA-mAbs) enables safe, ondemand mAb production within the patient, including in the lungs following nebulized delivery of mRNA-mAbs. Thus, our objective was to generate IVT mRNA encoding an equine mAb of the IgG1 …
-
TRANSLATION ENHANCEMENT OF IN-VITRO-TRANSCRIBED MESSENGER RNA BY INFLUENZA A VIRUS DERIVED NON-STRUCTURAL PROTEIN 1
… translation capacity of in vitro-transcribed (IVT) mRNA. Co-transfection of mRNA encoding NS1 and reporter gene mRNA enhanced reporter gene expression by over 10 times. NS1’s inhibition of interferon regulatory factor 3 (IRF3), protein kinase RNA-activated (PKR), and most importantly cleavage …
-
RNA Chimeric antigen receptor (CAR) T cell therapies for B cell mediated autoimmune diseases
… Therefore, non-viral, in vitro-transcribed (IVT) mRNA-based CAR platforms offer a controllable transient alternative. However, their utilization in therapeutic applications is heavily challenged by the rapid CAR expression decay caused by short RNA lifespan. To address these limitations, this …
-
Genome engineering to expand applications of human T-cell immunotherapy
… To this end, we first developed a linear mRNA expression vector with a long, encoded poly(A) tail to allow transient delivery of nucleases such as TALENs or CRISPR to primary human cells in a consistent, clinically applicable, and scalable fashion. We then used IVT mRNA made from this …
-
Click chemistry for the modification of oligonucleotides and their applications
… and in particular to DNA nanostructures, to mRNA to be then used in drug development and to produce highly labeled probes for fluorescent in situ hybridization. Continuing the previous work done at baseclick, at first click chemistry was applied on DNA nanostructures. In this field DNA, is …
-
mRNA Modification and delivery strategies towards the establishment of a platform for safe and effective gene therapy
… as to whether it was possible to effectively use mRNA for gene therapy. However, rapid advances in messenger RNA-based technologies in the last decade have transformed mRNA into an increasingly popular therapeutic modality, especially in the field of vaccination against cancer and viral …